Fetching the paper…
Reading the bibliography…
Drug discovery remains a formidable challenge: more than 90 percent of candidate molecules fail in clinical evaluation, and development costs often exceed one billion dollars per approved therapy.
Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research . 2000;28(1):27–30
2000
Earlier work this paper cites.
Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research . 2002;30(1):207–210
2002
Earlier work this paper cites.
Köster J, Rahmann S. Snakemake—a scalable bioinformatics workflow engine. Bioinformatics . 2012;28(19):2520–2522
2012
Earlier work this paper cites.
Waring MJ, Arrowsmith J, Leach AR, et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature Reviews Drug Discovery . 2015;14(7):475–486
2015
Earlier work this paper cites.
Gaulton A, Hersey A, Nowotka M, et al. The ChEMBL database in 2017. Nucleic Acids Research . 2017;45(D1):D945–D954
2017
Earlier work this paper cites.
Apache Airflow. 2017. https://airflow.apache.org/
2017
Earlier work this paper cites.
Di Tommaso P, et al. Nextflow enables reproducible computational workflows. Nature Biotechnology . 2017;35(4):316–319
2017
Earlier work this paper cites.
Wishart DS, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research . 2018;46(D1):D1074–D1082
2018
Earlier work this paper cites.
Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nature Reviews Drug Discovery . 2019;18:41–58
2019
Earlier work this paper cites.
Segler MHS, Preuss M, Waller M. Planning chemical syntheses with deep neural networks and symbolic AI. Nature . 2020;555:604–610
2020
Cited alongside, same era.
Sosa DN, Derry A, Guo M, Wei E, Brinton C, Altman RB. A literature-based knowledge graph embedding method for identifying drug repurposing opportunities in rare diseases. Pacific Symposium on Biocomputing . 2020:589–600
2020
Cited alongside, same era.
Jassal B, Matthews L, Viteri G, et al. The Reactome pathway knowledgebase. Nucleic Acids Research . 2020;48(D1):D498–D503
2020
Cited alongside, same era.
2021
Cited alongside, same era.
Rives A, Meier J, Sercu T, et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proceedings of the National Academy of Sciences . 2021;118(15):e2016239118
Nguyen T, et al. Agent-based climate modeling with language models. Geophysical Research Letters . 2023;50(10):e2022GL100123
2023
Later among the works it cites.
Wang Y, Jiang L, Zhou M, Smith NA. Evaluating multi-agent collaboration in large language models. In: Proceedings of the 61st Annual Meeting of the Association for Computational Linguistics (ACL) . 2023:2334–2346
2023
Later among the works it cites.
Ochoa D, Hercules A, Carmona M, et al. The Open Targets Platform: Re-imagining drug target identification. Nucleic Acids Research . 2023;51(D1):D1305–D1316
2023
Later among the works it cites.
Prefect. 2023. https://www.prefect.io/
2023
Later among the works it cites.
Kubeflow Pipelines. 2023. https://www.kubeflow.org/
2023
Later among the works it cites.
alphaXiv searches the wider corpus for related work and actual follow-ups.
alphaXiv is searching for related work…
2021
Cited alongside, same era.
2022
Cited alongside, same era.
2022
Cited alongside, same era.
OpenAI. GPT-4 Technical Report. arXiv:2303.08774. 2023
2023
Cited alongside, same era.
Pompe N, et al. Autonomous laboratory planning with multi-agent LLM systems. Nature Communications . 2023;14:2345
2023
Cited alongside, same era.
Argo Workflows. 2024. https://argoproj.github.io/argo-workflows/
2024
Later among the works it cites.
n8n. 2024. https://n8n.io/
2024
Later among the works it cites.
2025
Closest in time.
Song K, Chen JY. Integrative multi-scale network simulation for precision drug repurposing with PETS. bioRxiv . 2025
2025
Closest in time.